Paid Clinical Trials in Rapid City, SD
As of July 2026, 61 paid clinical trials are recruiting in Rapid City, South Dakota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Rapid City offers studies at sites including Rapid City Regional Hospital for conditions such as Heart Failure, Obesity, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Rapid City
Trials by drug in Rapid City
Filter results
Newly added in Rapid City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
56 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Melodi Matrix™ in Breast Reconstruction
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Family Communications After Genetic Testing
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
E-Mindfulness Approaches for Living After Breast Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Top Research Study Locations in Rapid City
Researchers run research studies in Rapid City, SD at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Rapid City Regional Hospital | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 15 |
| Monument Health | Heart Failure, Breast Reconstruction | 5 |
| Monument Health Clinical Research | Obesity, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation (AF) | 5 |
| Health Concepts | Gout, Moderate to Severe Chronic Obstructive Pulmonary Disease, Tophaceous Gout | 5 |
| Monument Health Clinical Rsrch | Obesity, Diabetes Mellitus, Type 2, Heart Failure | 3 |
| Black Hills Regional Eye Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-Related Macular Degeneration (nAMD) | 3 |
| Black Hills Center for American Indian Health | Smoking Cessation, Cigarette Smoking | 2 |
| Monument Health Rapid City Hospital | Breast Carcinoma, Colorectal Carcinoma, Lumbar Spinal Stenosis | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | 1 |
| Black Hills Surgical Hospital | Lumbar Spinal Stenosis | 1 |
| Care Access - Rapid City | Osteoarthritis | 1 |
| Center for Indigenous Health - Great Plains Hub | Diabetes | 1 |
| GSK Investigational Site | Asthma | 1 |
| Local Institution - 0084 | Plaque Psoriasis | 1 |
| Monument Health Cancer Care Institute | Triple Negative Breast Cancer | 1 |
| Monument Health Clinical Research, Monument Health Rapid City Hospital Inc. | Acute Myocardial Infarction | 1 |
| Monument Health Clinical Research, a department of Monument Health Rapid City Hospital, Inc. | Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Monument Health Heart and Vascular Institute | Aortic Stenosis, Aortic Valve Disease, Aortic Valve Stenosis | 1 |
| Ohio State University Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| Plastic Surgical Center of Rapid City | Lumbar Spinal Stenosis | 1 |
| Rapid City Medical Center, LLC | Moderately to Severely Active Crohn Disease | 1 |
| Rapid City Medical Center, LLP | Ulcerative Colitis | 1 |
| Same Day Surgery Center | Lumbar Spinal Stenosis | 1 |
| Sanford Health Research | Crohn's Disease | 1 |
| University of Michigan/Rapid City | Anxiety, Depression, Drug Use | 1 |
Active & Upcoming Studies in Rapid City (2026)
Recruiting trials in Rapid City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (18 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Diabetes & metabolic (7 active studies)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (4 active studies)
- Lakota Family Acceptance Project · University of Michigan
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Eye & vision (3 active studies)
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration · Phase 3 · 4D Molecular Therapeutics
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Common conditions studied in Rapid City
- Heart Failure (6 active studies)
- Obesity (4 active studies)
- Advanced Esophageal Adenocarcinoma (2 active studies)
- Advanced Gastric Adenocarcinoma (2 active studies)
- Advanced Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Cardiovascular Disease (2 active studies)
Leading research sponsors in Rapid City
- AstraZeneca
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Amgen
- Novo Nordisk A/S
Frequently asked questions
How many paid clinical trials are currently recruiting in Rapid City?
There are approximately 61 recruiting clinical trials in Rapid City, South Dakota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rapid City pay participants?
Most recruiting trials in Rapid City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rapid City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rapid City?
The most common conditions under active study in Rapid City include Heart Failure (6), Obesity (4), Advanced Esophageal Adenocarcinoma (2), Advanced Gastric Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rapid City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rapid City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rapid City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rapid City?
Recruiting research sites in Rapid City include Rapid City Regional Hospital, Monument Health, Monument Health Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rapid City right now?
The largest active categories in Rapid City are Cancer & tumors (18), Cardiovascular (10), Diabetes & metabolic (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.